{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T11:03:33Z","timestamp":1771758213263,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81100486 and 81370792"],"award-info":[{"award-number":["No. 81100486 and 81370792"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002767","name":"Hunan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["No. 2017SK2072"],"award-info":[{"award-number":["No. 2017SK2072"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Changsha Science and Technology Program of China","award":["kq1901122"],"award-info":[{"award-number":["kq1901122"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10753-019-01173-0","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T11:02:54Z","timestamp":1579086174000},"page":"878-891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Protein Phosphatase 2A Inhibiting \u03b2-Catenin Phosphorylation Contributes Critically to the Anti-renal Interstitial Fibrotic Effect of Norcantharidin"],"prefix":"10.1007","volume":"43","author":[{"given":"Zheng","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5590-0765","authenticated-orcid":false,"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,15]]},"reference":[{"key":"1173_CR1","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrneph.2013.146","volume":"9","author":"ZH Liu","year":"2013","unstructured":"Liu, Z.H. 2013. Nephrology in China. Nature Reviews. Nephrology 9: 523\u2013528.","journal-title":"Nature Reviews. Nephrology"},{"key":"1173_CR2","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster, A.C., E.V. Nagler, R.L. Morton, and P. Masson. 2017. Chronic kidney disease. Lancet 389: 1238\u20131252.","journal-title":"Lancet"},{"key":"1173_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1755-1536-7-4","volume":"7","author":"F Genovese","year":"2014","unstructured":"Genovese, F., A.A. Manresa, D.J. Leeming, M.A. Karsdal, and P. Boor. 2014. The extracellular matrix in the kidney: A source of novel non-invasive biomarkers of kidney fibrosis? Fibrogenesis & Tissue Repair 7: 4.","journal-title":"Fibrogenesis & Tissue Repair"},{"key":"1173_CR4","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrneph.2011.149","volume":"7","author":"Y Liu","year":"2011","unstructured":"Liu, Y. 2011. Cellular and molecular mechanisms of renal fibrosis. Nature Reviews. Nephrology 7: 684\u2013696.","journal-title":"Nature Reviews. Nephrology"},{"key":"1173_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biopha.2018.03.032","volume":"102","author":"MA Dkhil","year":"2018","unstructured":"Dkhil, M.A., R.B. Kassab, S. Al-Quraishy, M.M. Abdel-Daim, R. Zrieq, and A.E. Abdel Moneim. 2018. Ziziphus spina-christi (L.) leaf extract alleviates myocardial and renal dysfunction associated with sepsis in mice. Biomedicine & Pharmacotherapy 102: 64\u201375.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"1173_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00210-016-1332-5","volume":"390","author":"MM Abdel-Daim","year":"2017","unstructured":"Abdel-Daim, M.M., Y.S. El-Sayed, M.A. Eldaim, and A. Ibrahim. 2017. Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 390: 301\u2013309.","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"1173_CR7","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s10616-015-9860-2","volume":"68","author":"A Ibrahim","year":"2016","unstructured":"Ibrahim, A., M.A. Eldaim, and M.M. Abdel-Daim. 2016. Nephroprotective effect of bee honey and royal jelly against subchronic cisplatin toxicity in rats. Cytotechnology 68: 1039\u20131048.","journal-title":"Cytotechnology"},{"key":"1173_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/0886022X.2014.983017","volume":"37","author":"MM Abdel-Daim","year":"2015","unstructured":"Abdel-Daim, M.M., and A. El-Ghoneimy. 2015. Synergistic protective effects of ceftriaxone and ascorbic acid against subacute deltamethrin-induced nephrotoxicity in rats. Renal Failure 37: 297\u2013304.","journal-title":"Renal Failure"},{"key":"1173_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.biopha.2015.12.003","volume":"77","author":"M Abdel-Daim","year":"2016","unstructured":"Abdel-Daim, M., B.E. El-Bialy, H.G. Rahman, A.M. Radi, H.A. Hefny, and A.M. Hassan. 2016. Antagonistic effects of Spirulina platensis against sub-acute deltamethrin toxicity in mice: Biochemical and histopathological studies. Biomedicine & Pharmacotherapy 77: 79\u201385.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"1173_CR10","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1681\/ASN.2010080793","volume":"21","author":"M Zeisberg","year":"2010","unstructured":"Zeisberg, M., and E.G. Neilson. 2010. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21: 1819\u20131834.","journal-title":"J Am Soc Nephrol"},{"key":"1173_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.bcp.2013.10.025","volume":"87","author":"O Kadioglu","year":"2014","unstructured":"Kadioglu, O., N.S. Kermani, G. Kelter, U. Schumacher, H.H. Fiebig, H.J. Greten, and T. Efferth. 2014. Pharmacogenomics of cantharidin in tumor cells. Biochemical Pharmacology 87: 399\u2013409.","journal-title":"Biochemical Pharmacology"},{"key":"1173_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/cas.12120","volume":"104","author":"L Zhang","year":"2013","unstructured":"Zhang, L., et al. 2013. Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2\/MEK\/ERK signaling pathways. Cancer Science 104: 604\u2013610.","journal-title":"Cancer Science"},{"key":"1173_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/0886022X.2011.553305","volume":"33","author":"Y Li","year":"2011","unstructured":"Li, Y., et al. 2011. Norcantharidin attenuates tubulointerstitial fibrosis in rat models with diabetic nephropathy. Renal Failure 33: 233\u2013241.","journal-title":"Renal Failure"},{"key":"1173_CR14","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1159\/000112850","volume":"28","author":"FY Liu","year":"2008","unstructured":"Liu, F.Y., et al. 2008. Norcantharidin ameliorates proteinuria, associated tubulointerstitial inflammation and fibrosis in protein overload nephropathy. American Journal of Nephrology 28: 465\u2013477.","journal-title":"American Journal of Nephrology"},{"key":"1173_CR15","doi-asserted-by":"publisher","first-page":"e66356","DOI":"10.1371\/journal.pone.0066356","volume":"8","author":"Y Li","year":"2013","unstructured":"Li, Y., et al. 2013. Norcantharidin inhibits renal interstitial fibrosis by blocking the tubular epithelial-mesenchymal transition. PLoS One 8: e66356.","journal-title":"PLoS One"},{"key":"1173_CR16","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/0959-8049(95)00050-X","volume":"31a","author":"XH Liu","year":"1995","unstructured":"Liu, X.H., et al. 1995. Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells. European Journal of Cancer 31a: 953\u2013963.","journal-title":"European Journal of Cancer"},{"key":"1173_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.biocel.2017.10.008","volume":"96","author":"CM O'Connor","year":"2018","unstructured":"O'Connor, C.M., A. Perl, D. Leonard, J. Sangodkar, and G. Narla. 2018. Therapeutic targeting of PP2A. The International Journal of Biochemistry & Cell Biology 96: 182\u2013193.","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"1173_CR18","first-page":"2199","volume":"7","author":"T Hou","year":"2015","unstructured":"Hou, T., et al. 2015. Norcantharidin inhibits renal interstitial fibrosis by downregulating PP2Ac expression. American Journal of Translational Research 7: 2199\u20132211.","journal-title":"American Journal of Translational Research"},{"key":"1173_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/bs.pmbts.2017.11.019","volume":"153","author":"Y Wang","year":"2018","unstructured":"Wang, Y., C.J. Zhou, and Y. Liu. 2018. Wnt signaling in kidney development and disease. Progress in Molecular Biology and Translational Science 153: 181\u2013207.","journal-title":"Progress in Molecular Biology and Translational Science"},{"key":"1173_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/1878-0261.12100","volume":"12","author":"AI Sagredo","year":"2018","unstructured":"Sagredo, A.I., et al. 2018. TRPM4 regulates Akt\/GSK3-beta activity and enhances beta-catenin signaling and cell proliferation in prostate cancer cells. Molecular Oncology 12: 151\u2013165.","journal-title":"Molecular Oncology"},{"key":"1173_CR21","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1111\/jcmm.13446","volume":"22","author":"T Cai","year":"2018","unstructured":"Cai, T., D. Sun, Y. Duan, Y. Qiu, C. Dai, J. Yang, and W. He. 2018. FHL2 promotes tubular epithelial-to-mesenchymal transition through modulating beta-catenin signalling. Journal of Cellular and Molecular Medicine 22: 1684\u20131695.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"1173_CR22","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1681\/ASN.2010101079","volume":"22","author":"S Hao","year":"2011","unstructured":"Hao, S., et al. 2011. Targeted inhibition of beta-catenin\/CBP signaling ameliorates renal interstitial fibrosis. J Am Soc Nephrol 22: 1642\u20131653.","journal-title":"J Am Soc Nephrol"},{"key":"1173_CR23","first-page":"289","volume":"23","author":"M Li","year":"2019","unstructured":"Li, M., H. Zhou, J. Di, M. Yang, and F. Jia. 2019. ILK participates in renal interstitial fibrosis by altering the phenotype of renal tubular epithelial cells via TGF-beta1\/smad pathway. European Review for Medical and Pharmacological Sciences 23: 289\u2013296.","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"1173_CR24","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1111\/bph.14333","volume":"175","author":"M Wang","year":"2018","unstructured":"Wang, M., et al. 2018. Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt\/beta-catenin pathway against renal fibrosis. British Journal of Pharmacology 175: 2689\u20132708.","journal-title":"British Journal of Pharmacology"},{"key":"1173_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000370250","volume":"41","author":"L Yao","year":"2015","unstructured":"Yao, L., et al. 2015. High phosphorus level leads to aortic calcification via beta-catenin in chronic kidney disease. American Journal of Nephrology 41: 28\u201336.","journal-title":"American Journal of Nephrology"},{"key":"1173_CR26","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1128\/MCB.01307-14","volume":"35","author":"N Yu","year":"2015","unstructured":"Yu, N., et al. 2015. HSP105 recruits protein phosphatase 2A to dephosphorylate beta-catenin. Molecular and Cellular Biology 35: 1390\u20131400.","journal-title":"Molecular and Cellular Biology"},{"key":"1173_CR27","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1158\/1535-7163.MCT-16-0584","volume":"16","author":"S Maheshwari","year":"2017","unstructured":"Maheshwari, S., et al. 2017. Discovery of a novel small-molecule inhibitor that targets PP2A-beta-catenin signaling and restricts tumor growth and metastasis. Molecular Cancer Therapeutics 16: 1791\u20131805.","journal-title":"Molecular Cancer Therapeutics"},{"key":"1173_CR28","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.kint.2018.12.031","volume":"95","author":"C Lavoz","year":"2019","unstructured":"Lavoz, C., Y.S. Matus, M. Orejudo, J.D. Carpio, A. Droguett, J. Egido, S. Mezzano, and M. Ruiz-Ortega. 2019. Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy. Kidney International 95: 1418\u20131432.","journal-title":"Kidney International"},{"key":"1173_CR29","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ki.2010.88","volume":"77","author":"O Garcia-Sanchez","year":"2010","unstructured":"Garcia-Sanchez, O., F.J. Lopez-Hernandez, and J.M. Lopez-Novoa. 2010. An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease. Kidney International 77: 950\u2013955.","journal-title":"Kidney International"},{"key":"1173_CR30","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/labinvest.2011.119","volume":"91","author":"Y Li","year":"2011","unstructured":"Li, Y., et al. 2011. Norcantharidin inhibits the expression of extracellular matrix and TGF-beta1 in HK-2 cells induced by high glucose independent of calcineurin signal pathway. Laboratory Investigation 91: 1706\u20131716.","journal-title":"Laboratory Investigation"},{"key":"1173_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/kisup.2014.16","volume":"4","author":"RJ Tan","year":"2014","unstructured":"Tan, R.J., D. Zhou, L. Zhou, and Y. Liu. 2014. Wnt\/beta-catenin signaling and kidney fibrosis. Kidney International. Supplement (2011 4: 84\u201390.","journal-title":"Kidney International. Supplement"},{"key":"1173_CR32","doi-asserted-by":"publisher","first-page":"31526","DOI":"10.1074\/jbc.M114.584565","volume":"289","author":"M Matsuyama","year":"2014","unstructured":"Matsuyama, M., A. Nomori, K. Nakakuni, A. Shimono, and M. Fukushima. 2014. Secreted frizzled-related protein 1 (Sfrp1) regulates the progression of renal fibrosis in a mouse model of obstructive nephropathy. The Journal of Biological Chemistry 289: 31526\u201331533.","journal-title":"The Journal of Biological Chemistry"},{"key":"1173_CR33","first-page":"230","volume":"28","author":"SE Conduit","year":"2019","unstructured":"Conduit, S.E., S. Hakim, S.J. Feeney, L.M. Ooms, J.M. Dyson, H.E. Abud, and C.A. Mitchell. 2019. Beta-catenin ablation exacerbates polycystic kidney disease progression. Human Molecular Genetics 28: 230\u2013244.","journal-title":"Human Molecular Genetics"},{"key":"1173_CR34","doi-asserted-by":"publisher","first-page":"e84852","DOI":"10.1371\/journal.pone.0084852","volume":"9","author":"XD Wang","year":"2014","unstructured":"Wang, X.D., X.F. Huang, Q.R. Yan, and C.D. Bao. 2014. Aberrant activation of the WNT\/beta-catenin signaling pathway in lupus nephritis. PLoS One 9: e84852.","journal-title":"PLoS One"},{"key":"1173_CR35","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1111\/jcmm.14340","volume":"23","author":"X Huang","year":"2019","unstructured":"Huang, X., H. Xue, J. Ma, Y. Zhang, J. Zhang, Y. Liu, X. Qin, and C. Sun. 2019. Salidroside ameliorates Adriamycin nephropathy in mice by inhibiting beta-catenin activity. Journal of Cellular and Molecular Medicine 23: 4443\u20134453.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"1173_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11010-015-2569-x","volume":"411","author":"S Duan","year":"2016","unstructured":"Duan, S., Y. Wu, C. Zhao, M. Chen, Y. Yuan, C. Xing, and B. Zhang. 2016. The wnt\/beta-catenin signaling pathway participates in rhein ameliorating kidney injury in DN mice. Molecular and Cellular Biochemistry 411: 73\u201382.","journal-title":"Molecular and Cellular Biochemistry"},{"key":"1173_CR37","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1083\/jcb.201712041","volume":"217","author":"KA White","year":"2018","unstructured":"White, K.A., B.K. Grillo-Hill, M. Esquivel, J. Peralta, V.N. Bui, I. Chire, and D.L. Barber. 2018. Beta-catenin is a pH sensor with decreased stability at higher intracellular pH. The Journal of Cell Biology 217: 3965\u20133976.","journal-title":"The Journal of Cell Biology"},{"key":"1173_CR38","doi-asserted-by":"crossref","unstructured":"Thompson, J.J., and C.S. Williams. 2018. Protein phosphatase 2A in the regulation of Wnt signaling, stem cells, and cancer. Genes (Basel) 9.","DOI":"10.3390\/genes9030121"},{"key":"1173_CR39","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1038\/onc.2011.623","volume":"31","author":"A Mitra","year":"2012","unstructured":"Mitra, A., M.E. Menezes, L.K. Pannell, M.S. Mulekar, R.E. Honkanen, L.A. Shevde, and R.S. Samant. 2012. DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3beta to downregulate beta-catenin transcription target, osteopontin. Oncogene 31: 4472\u20134483.","journal-title":"Oncogene"},{"key":"1173_CR40","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/mc.22217","volume":"54","author":"M Carmen Figueroa-Aldariz","year":"2015","unstructured":"Carmen Figueroa-Aldariz, M., M.C. Castaneda-Patlan, P. Santoyo-Ramos, A. Zentella, and M. Robles-Flores. 2015. Protein phosphatase 2A is essential to maintain active Wnt signaling and its Abeta tumor suppressor subunit is not expressed in colon cancer cells. Molecular Carcinogenesis 54: 1430\u20131441.","journal-title":"Molecular Carcinogenesis"},{"key":"1173_CR41","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.2174\/1389557511313080005","volume":"13","author":"L Deng","year":"2013","unstructured":"Deng, L., J. Dong, and W. Wang. 2013. Exploiting protein phosphatase inhibitors based on cantharidin analogues for cancer drug discovery. Mini Reviews in Medicinal Chemistry 13: 1166\u20131176.","journal-title":"Mini Reviews in Medicinal Chemistry"},{"key":"1173_CR42","unstructured":"Deng, L., S. Tang, and Q. Qian. 2012. A review for mini-review in medicinal chemistry. Mini Reviews in Medicinal Chemistry."},{"key":"1173_CR43","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.3892\/or.2016.4559","volume":"35","author":"D Xie","year":"2016","unstructured":"Xie, D., J. Xie, Y. Wan, L. Ma, X. Qi, K. Wang, and S. Yang. 2016. Norcantharidin blocks Wnt\/beta-catenin signaling via promoter demethylation of WIF-1 in glioma. Oncology Reports 35: 2191\u20132197.","journal-title":"Oncology Reports"},{"key":"1173_CR44","doi-asserted-by":"publisher","first-page":"415","DOI":"10.7150\/ijbs.8002","volume":"10","author":"S Lu","year":"2014","unstructured":"Lu, S., Y. Gao, X. Huang, and X. Wang. 2014. Cantharidin exerts anti-hepatocellular carcinoma by miR-214 modulating macrophage polarization. International Journal of Biological Sciences 10: 415\u2013425.","journal-title":"International Journal of Biological Sciences"},{"key":"1173_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12032-015-0592-0","volume":"32","author":"J Xie","year":"2015","unstructured":"Xie, J., Y. Zhang, X. Hu, R. Lv, D. Xiao, L. Jiang, and Q. Bao. 2015. Norcantharidin inhibits Wnt signal pathway via promoter demethylation of WIF-1 in human non-small cell lung cancer. Medical Oncology 32: 145.","journal-title":"Medical Oncology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-019-01173-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-019-01173-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-019-01173-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T07:27:17Z","timestamp":1610609237000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-019-01173-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,15]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1173"],"URL":"https:\/\/doi.org\/10.1007\/s10753-019-01173-0","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,15]]},"assertion":[{"value":"15 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}